Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline Journal Article

Authors: Paice, J. A.; Portenoy, R.; Lacchetti, C.; Campbell, T.; Cheville, A.; Citron, M.; Constine, L. S.; Cooper, A.; Glare, P.; Keefe, F.; Koyyalagunta, L.; Levy, M.; Miaskowski, C.; Otis-Green, S.; Sloan, P.; Bruera, E.
Article Title: Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline
Abstract: Purpose: To provide evidence-based guidance on the optimum management of chronic pain in adult cancer survivors. Methods: An ASCO-convened expert panel conducted a systematic literature search of studies investigating chronic pain management in cancer survivors. Outcomes of interest included symptom relief, pain intensity, quality of life, functional outcomes, adverse events, misuse or diversion, and risk assessment or mitigation. Results: A total of 63 studies met eligibility criteria and compose the evidentiary basis for the recommendations. Studies tended to be heterogeneous in terms of quality, size, and populations. Primary outcomes also varied across the studies, and in most cases, were not directly comparable because of different outcomes, measurements, and instruments used at different time points. Because of a paucity of high-quality evidence, many recommendations are based on expert consensus. Recommendations: Clinicians should screen for pain at each encounter. Recurrent disease, second malignancy, or late-onset treatment effects in any patient who reports new-onset pain should be evaluated, treated, and monitored. Clinicians should determine the need for other health professionals to provide comprehensive pain management care in patients with complex needs. Systemic nonopioid analgesics and adjuvant analgesics may be prescribed to relieve chronic pain and/or to improve function. Clinicians may prescribe a trial of opioids in carefully selected patients with cancer who do not respond to more conservative management and who continue to experience distress or functional impairment. Risks of adverse effects of opioids should be assessed. Clinicians should clearly understand terminology such as tolerance, dependence, abuse, and addiction as it relates to the use of opioids and should incorporate universal precautions to minimize abuse, addiction, and adverse consequences. Additional information is available at and © 2016 by American Society of Clinical Oncology.
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 27
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-09-20
Start Page: 3325
End Page: 3345
Language: English
DOI: 10.1200/jco.2016.68.5206
PROVIDER: scopus
PUBMED: 27458286
Notes: Article -- Export Date: 2 November 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. Paul A Glare
    56 Glare